TechnologiesTechnologiesTechnologiesTechnologies
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Technologies

  • Home
  • Technologies

Innovita Research has developed some experimental technologies that can be provided for scientific and other customers. In many cases we can help with the preparation and application of these technologies under customer local governmental rules/requirements.

  • Cancer immunotherapy
  • T-cell immunotherapy (T-cell vaccination) for autoimmune and allergic disorders
  • Adoptive cell-based immunotherapy for chronic inflammatory diseases
  • OPI therapy for motor and skin diseases
  • Storage of immune cells

Related science news

  • Brain discovery opens door to earlier detection of metabolic syndrome in women
    December 10, 2025
  • Neurodegenerative Breakthroughs: How Stem Cell Models Are Quietly Changing Parkinson’s and Alzheimer’s Research
    December 9, 2025
  • Common Brain Network Links Brain Atrophy Patterns Seen in Schizophrenia
    December 8, 2025
  • Erastin – A Chem-Biological Perspective on a Groundbreaking Small Molecule
    November 27, 2025
  • AI tool spots blood cell abnormalities missed by doctors
    November 26, 2025
More news.
© 2017 - 2025 Innovita Research | Privacy policy